Skip to main content

Peer Review reports

From: Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial

Original Submission
6 Apr 2006 Submitted Original manuscript
13 Apr 2006 Reviewed Reviewer Report - Maurie Markman
19 Apr 2006 Reviewed Reviewer Report - Richard Penson
20 May 2006 Author responded Author comments - Massimo Di Maio
Resubmission - Version 2
20 May 2006 Submitted Manuscript version 2
25 May 2006 Reviewed Reviewer Report - Maurie Markman
26 May 2006 Reviewed Reviewer Report - Richard Penson
13 Jun 2006 Author responded Author comments - Massimo Di Maio
Resubmission - Version 3
13 Jun 2006 Submitted Manuscript version 3
28 Jun 2006 Author responded Author comments - Massimo Di Maio
Resubmission - Version 4
28 Jun 2006 Submitted Manuscript version 4
Publishing
1 Aug 2006 Editorially accepted
1 Aug 2006 Article published 10.1186/1471-2407-6-202

You can find further information about peer review here.

Back to article page